AngioDynamics, Inc. NASDAQ:ANGO

AngioDynamics stock price today

$8.82
-0.08
-1.01%
Financial Health
0
1
2
3
4
5
6
7
8
9

AngioDynamics stock price monthly change

+48.50%
month

AngioDynamics stock price quarterly change

+48.50%
quarter

AngioDynamics stock price yearly change

+10.82%
year

AngioDynamics key metrics

Market Cap
355.34M
Enterprise value
397.40M
P/E
-10.06
EV/Sales
1.18
EV/EBITDA
-62.84
Price/Sales
1.12
Price/Book
0.94
PEG ratio
-0.58
EPS
-5.61
Revenue
333.96M
EBITDA
6.76M
Income
-224.95M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
-11.13%
Oper. margin
-10.98%
Gross margin
52.09%
EBIT margin
-10.98%
EBITDA margin
2.02%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

AngioDynamics stock price history

AngioDynamics stock forecast

AngioDynamics financial statements

AngioDynamics, Inc. (NASDAQ:ANGO): Profit margin
May 2022 86.99M -6.26M -7.2%
Feb 2023 80.71M -9.48M -11.75%
May 2023 91.07M -21.46M -23.57%
Feb 2024 75.18M -187.73M -249.71%
AngioDynamics, Inc. (NASDAQ:ANGO): Analyst Estimates
2028 388.21M 21.71M 5.59%
  • Analysts Price target

  • Financials & Ratios estimates

AngioDynamics, Inc. (NASDAQ:ANGO): Earnings per share (EPS)
2024-10-03 -0.15 -0.11
AngioDynamics, Inc. (NASDAQ:ANGO): Debt to assets
Nov 2022 558207000 150.24M 26.92%
Feb 2023 542849000 145.19M 26.75%
May 2023 532637000 154.34M 28.98%
Feb 2024 324842000 106.14M 32.68%
AngioDynamics, Inc. (NASDAQ:ANGO): Cash Flow
May 2022 8.56M -3.77M 329K
Feb 2023 1.37M -2.14M 941K
May 2023 15.95M -1.52M -751K
Feb 2024 -12.52M 29.40M 694K

AngioDynamics alternative data

AngioDynamics, Inc. (NASDAQ:ANGO): Employee count
Sep 2023 815
Oct 2023 815
Nov 2023 815
Dec 2023 815
Jan 2024 815
Feb 2024 815
Mar 2024 815
Apr 2024 815
May 2024 815
Jun 2024 815
Jul 2024 815

AngioDynamics other data

56.88% -37.20%
of ANGO is owned by hedge funds
22.47M -14.67M
shares is hold by hedge funds

AngioDynamics, Inc. (NASDAQ:ANGO): Insider trades (number of shares)
Period Buy Sel
Apr 2024 10000 0
Oct 2024 22568 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
NIGHAN WARREN JR officer: SVP Quality and Regula..
Common Stock 100 $6.08 $608
Purchase
TROWBRIDGE STEPHEN A officer: EVP and .. Common Stock 1,700 $5.86 $9,962
Purchase
NIGHAN WARREN JR officer: SVP Quality and Regula..
Common Stock 768 $6.09 $4,677
Purchase
CLEMMER JAMES C director, officer.. Common Stock 20,000 $6.03 $120,600
Option
PICCININI LAURA officer: SVP International
Common Stock 4,439 N/A N/A
Option
PICCININI LAURA officer: SVP International
Performance Right 5,903 N/A N/A
Option
CLEMMER JAMES C director, officer.. Common Stock 56,279 N/A N/A
Option
CLEMMER JAMES C director, officer.. Performance Right 52,378 N/A N/A
Option
NIGHAN WARREN JR officer: SVP Quality and Regula..
Common Stock 5,677 N/A N/A
Option
NIGHAN WARREN JR officer: SVP Quality and Regula..
Performance Right 7,550 N/A N/A
Patent
Application
Filling date: 20 Apr 2022 Issue date: 11 Aug 2022
Application
Filling date: 16 Dec 2021 Issue date: 7 Apr 2022
Grant
Filling date: 8 Jan 2018 Issue date: 25 Jan 2022
Application
Filling date: 14 Jun 2021 Issue date: 2 Dec 2021
Application
Filling date: 4 Jun 2021 Issue date: 25 Nov 2021
Grant
Filling date: 5 Jan 2021 Issue date: 16 Nov 2021
Application
Filling date: 13 Apr 2021 Issue date: 14 Oct 2021
Grant
Filling date: 9 Mar 2021 Issue date: 21 Sep 2021
Application
Filling date: 8 Feb 2021 Issue date: 9 Sep 2021
Application
Filling date: 1 Apr 2021 Issue date: 22 Jul 2021
Insider Compensation
Mr. James C. Clemmer (1964) Chief Executive Officer, Pres & Director $1,910,000
Mr. Stephen A. Trowbridge (1974) Executive Vice President & Chief Financial Officer $812,990
Mr. David D. Helsel (1964) Senior Vice President of Global Operations and R&D
$664,290
Mr. Warren G. Nighan (1969) Senior Vice President of Quality & Regulatory Affairs
$622,110
Mr. Chad T. Campbell (1971) Senior Vice President & GM of Vascular Access Global Bus. Unit $589,750
Thursday, 19 December 2024
businesswire.com
Tuesday, 10 December 2024
zacks.com
zacks.com
Monday, 9 December 2024
businesswire.com
Friday, 1 November 2024
zacks.com
Tuesday, 29 October 2024
zacks.com
Wednesday, 23 October 2024
zacks.com
Tuesday, 8 October 2024
zacks.com
Friday, 4 October 2024
zacks.com
Thursday, 3 October 2024
zacks.com
fool.com
benzinga.com
zacks.com
businesswire.com
benzinga.com
Monday, 30 September 2024
zacks.com
Monday, 23 September 2024
zacks.com
Thursday, 19 September 2024
businesswire.com
businesswire.com
Friday, 13 September 2024
zacks.com
Monday, 9 September 2024
zacks.com
Wednesday, 4 September 2024
zacks.com
Tuesday, 27 August 2024
zacks.com
Wednesday, 14 August 2024
zacks.com
Thursday, 1 August 2024
zacks.com
Monday, 29 July 2024
zacks.com
zacks.com
Wednesday, 17 July 2024
seekingalpha.com
zacks.com
Tuesday, 16 July 2024
benzinga.com
  • What's the price of AngioDynamics stock today?

    One share of AngioDynamics stock can currently be purchased for approximately $8.82.

  • When is AngioDynamics's next earnings date?

    AngioDynamics, Inc. is estimated to report earnings on Wednesday, 1 Oct 2025.

  • Does AngioDynamics pay dividends?

    No, AngioDynamics does not pay dividends.

  • How much money does AngioDynamics make?

    AngioDynamics has a market capitalization of 355.34M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 10.28% to 303.91M US dollars. AngioDynamics made a loss 184.35M US dollars in net income (profit) last year or -$0.11 on an earnings per share basis.

  • What is AngioDynamics's stock symbol?

    AngioDynamics, Inc. is traded on the NASDAQ under the ticker symbol "ANGO".

  • What is AngioDynamics's primary industry?

    Company operates in the Healthcare sector and Medical - Instruments & Supplies industry.

  • How do i buy shares of AngioDynamics?

    Shares of AngioDynamics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are AngioDynamics's key executives?

    AngioDynamics's management team includes the following people:

    • Mr. James C. Clemmer Chief Executive Officer, Pres & Director(age: 61, pay: $1,910,000)
    • Mr. Stephen A. Trowbridge Executive Vice President & Chief Financial Officer(age: 51, pay: $812,990)
    • Mr. David D. Helsel Senior Vice President of Global Operations and R&D(age: 61, pay: $664,290)
    • Mr. Warren G. Nighan Senior Vice President of Quality & Regulatory Affairs(age: 56, pay: $622,110)
    • Mr. Chad T. Campbell Senior Vice President & GM of Vascular Access Global Bus. Unit(age: 54, pay: $589,750)
  • How many employees does AngioDynamics have?

    As Jul 2024, AngioDynamics employs 815 workers.

  • When AngioDynamics went public?

    AngioDynamics, Inc. is publicly traded company for more then 21 years since IPO on 1 Jun 2004.

  • What is AngioDynamics's official website?

    The official website for AngioDynamics is angiodynamics.com.

  • Where are AngioDynamics's headquarters?

    AngioDynamics is headquartered at 14 Plaza Drive, Latham, NY.

  • How can i contact AngioDynamics?

    AngioDynamics's mailing address is 14 Plaza Drive, Latham, NY and company can be reached via phone at +51 87 951400.

AngioDynamics company profile:

AngioDynamics, Inc.

angiodynamics.com
Exchange:

NASDAQ

Full time employees:

748

Industry:

Medical - Instruments & Supplies

Sector:

Healthcare

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.

14 Plaza Drive
Latham, NY 12110

CIK: 0001275187
ISIN: US03475V1017
CUSIP: 03475V101